0
0
Read Time:12 Second
The U.S.based drug maker Johnson & Johnson has announced that it will not enforce patents for Sirturo — its brand name for bedaquiline, which is used in the treatment of multidrugresistant tuberculosis — in 134 low and middleincome countries. The…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %